Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma Meeting Abstract


Authors: Buxton, M.; Alexander, B.; Berry, D.; Cavenee, W.; Colman, H.; de Groot, J.; Ellingson, B.; Gordon, G.; Khasraw, M.; Lassman, A.; Lee, E.; Li, W.; Lim, M.; Mellinghoff, I.; Mikkelsen, T.; Nelli, A.; Perry, J.; Sulman, E.; Tanner, K.; Weller, M.; Wen, P. Y.; Alfred Yung, W. K.; Cloughesy, T.
Abstract Title: Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
Meeting Title: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 24
Issue: Suppl. 7
Meeting Dates: 2022 Nov 16-20
Meeting Location: Tampa Bay, FL
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2022-11-01
Start Page: vii80
Language: English
ACCESSION: WOS:000888571000306
PROVIDER: wos
DOI: 10.1093/neuonc/noac209.303
Notes: Meeting Abstract: CTNI-38 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors